Today, shares of GBS (NASDAQ:GBS) are skyrocketing following news that “the company will start preparation for clinical trials of its rapid SARS-CoV-2 antibody test.” GBS’s antibody test utilizes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results